Documents & Downloads

AGM-130

CDK Inhibitor

AGM-130 is a selective cyclin-dependent kinase (CDK) inhibitor that interferes with cell cycle progression. It has demonstrated significant antitumor activity, making it a valuable tool for cancer research. This compound can be utilized in studies aimed at understanding CDK modulation and its potential therapeutic implications in oncology.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	1459216-10-4
Applications	CDK Inhibitor
Formula	C₁₆H₁₀N₄O₅
Molecular Weight	338.27
SMILES	O=C(N1)/C(C2=C1C=CC([N+]([O-])=O)=C2)=C3/C(C(C=C(O)C=C4)=C4N3)=N/O

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.